These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6539476)

  • 1. Kinetic analysis of central nervous system supersensitivity induced in rats by long-term haloperidol administration. I. pA2 determination.
    Palermo-Neto J; Bernardi MM; Saban R
    Pharmacology; 1984; 28(4):203-10. PubMed ID: 6539476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of single and long-term metoclopramide administration on open field and stereotyped behavior of rats.
    Frussa-Filho R; Palermo-Neto J
    Eur J Pharmacol; 1988 May; 149(3):323-9. PubMed ID: 3409956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of apomorphine administration on rearing activity of control and experimental rats withdrawn from long-term haloperidol treatment.
    Bernardi MM; Palermo-Neto J
    Gen Pharmacol; 1984; 15(4):363-5. PubMed ID: 6541605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of scopolamine pretreatment on stereotyped behavior induced by apomorphine in rats withdrawn from long-term haloperidol administration.
    De-Souza H; Palermo-Neto J
    Braz J Med Biol Res; 1981 Oct; 14(4-5):281-4. PubMed ID: 7201335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding.
    Pierce RC; Rowlett JK; Bardo MT; Rebec GV
    Neuroscience; 1991; 45(2):373-8. PubMed ID: 1762684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
    Jenner P; Hall MD; Murugaiah K; Rupniak N; Theodorou A; Marsden CD
    Biochem Pharmacol; 1982 Feb; 31(3):325-8. PubMed ID: 7200363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monosialoganglioside increased the in vivo affinity of D2 receptors for apomorphine in supersensitive rats.
    Vital MB; Frussa-Filho R; Palermo-Neto J
    Ann N Y Acad Sci; 1998 Jun; 845():428-9. PubMed ID: 9668390
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetic analysis of GM1 effects on haloperidol-induced dopaminergic supersensitivity.
    Palermo-Neto J; Frussa-Filho R; Vital MA
    Gen Pharmacol; 1999 Feb; 32(2):265-70. PubMed ID: 10188630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide.
    Hassan MN; Reches A; Kuhn C; Higgins D; Fahn S
    Clin Neuropharmacol; 1986; 9(1):71-8. PubMed ID: 3829008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic autoreceptor blockade and neuroleptic-induced dopamine receptor hypersensitivity.
    Gordon JH; Clopton JK; Curtin JC; Koller WC
    Pharmacol Biochem Behav; 1987 Feb; 26(2):223-8. PubMed ID: 3575347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radio-frequency analysis of the effect of haloperidol and cyclo (leucyl-glycyl) on apomorphine-induced stereotypy.
    Fields JZ; Gonzalez LP; Meyerson LR; Lieber P; Lee JM; Steece KA; DeLeon-Jones FA; Ritzmann RF
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1279-84. PubMed ID: 3809231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
    Butkerait P; Friedman E
    Eur J Pharmacol; 1988 Mar; 148(2):269-72. PubMed ID: 2897925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of the intracaudate administration of kainic acid on the effects of the prolonged use of haloperidol and apomorphine on rats].
    Zharkovskiĭ AM; Allikmets LKh; Nurk AM
    Farmakol Toksikol; 1982; 45(1):10-2. PubMed ID: 7198997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dietary haloperidol regimen for inducing dopamine receptor supersensitivity in rats.
    Frey JM; Morgan WW; Ticku MK; Huffman RD
    Pharmacol Biochem Behav; 1987 Apr; 26(4):661-9. PubMed ID: 3602028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of chronic haloperidol administration on GABA receptor binding.
    Huffman RD; Ticku MK
    Pharmacol Biochem Behav; 1983 Aug; 19(2):199-204. PubMed ID: 6314387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
    Perry JC; Vital MA; Frussa-Filho R; Tufik S; Palermo-Neto J
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):127-33. PubMed ID: 15013028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR
    Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.